The percentage of tumor cells that were positive for the Ki-67 biomarker was 20.5 ± 6.4%, 22.9 ± 7.3%, and 9.2 ± 5.6% for the control, non-hibernating plasma, and hibernating plasma groups, respectively. The gene discussed is MKI67; the disease is neoplasm.